Plain-English translation of NCT07022496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Migraine research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether caffeine tablets extracted from green tea can help reduce the severity of migraine attacks when added to standard migraine treatments. Researchers want to know if this medication can make migraines feel less intense for people who suffer from them. You would be compared to people receiving only standard migraine treatment to see if adding caffeine makes a real difference.
Many migraine sufferers look for ways to make their attacks less severe. While caffeine is already used in some migraine medications, this trial wants to see if adding this treatment on top of standard care can provide extra relief for people struggling with acute migraine attacks.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would visit the headache and neurology clinic where you would be randomly assigned to either take caffeine tablets along with your standard migraine medication, or to continue with standard treatment alone. During the trial, you would report how severe your migraines feel using a pain scale, allowing researchers to compare whether adding the medication helps reduce migraine intensity compared to standard treatment by itself.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Egypt